A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This prospective observational study will investigate the effect of tocilizumab on fatigue in
participants with moderate to severe rheumatoid arthritis who have an inadequate response to
disease-modifying antirheumatic drugs or anti-tumour necrosis factor (anti-TNF) drugs. Data
will be collected from participants for 6 months.